Literature DB >> 18270821

Lack of association between down syndrome and polymorphisms in dopamine receptor D4 and serotonin transporter genes.

Aneek Das Bhowmik1, Samikshan Dutta, Swagata Sinha, Anindita Chattopadhyay, Kanchan Mukhopadhyay.   

Abstract

Down Syndrome (DS) patients suffer from cognitive dysfunction, depression, hyperactivity, irritability etc. Dopamine (DA) and serotonin (5HT) are known to control cognitive and behavioral attributes. An increased number of the DA receptor 4 (DRD4) is detected in brain regions primarily involved in cognition. Impairments in executive function have also been reported with depletion in 5HT. A variable number of tandem repeat (VNTR) in the exon 3 of DRD4 and an insertion/deletion polymorphism in the promoter region of 5HT transporter (5HTTLPR) have been found to be associated with different neurobehavioral disorders; however, association of these polymorphisms with DS has never been explored. The present family-based analysis on DS revealed significant over-transmission of a DRD4 VNTR allele which encodes for D4 receptor with average activity. No association was noticed for the 5HTTLPR. We may conclude that these genetic polymorphisms are not contributing to the neuromotor and cognitive dysfunctions observed in DS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18270821     DOI: 10.1007/s11064-007-9581-9

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  38 in total

1.  Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder.

Authors:  J Deckert; M Catalano; Y V Syagailo; M Bosi; O Okladnova; D Di Bella; M M Nöthen; P Maffei; P Franke; J Fritze; W Maier; P Propping; H Beckmann; L Bellodi; K P Lesch
Journal:  Hum Mol Genet       Date:  1999-04       Impact factor: 6.150

2.  Analysis of monoamine oxidase A promoter polymorphism in mentally retarded individuals.

Authors:  Aneek Das Bhowmik; Manali Das; Swagata Sinha; Kanchan Mukhopadhyay
Journal:  Psychiatr Genet       Date:  2007-02       Impact factor: 2.458

Review 3.  Down syndrome: advances in molecular biology and the neurosciences.

Authors:  G T Capone
Journal:  J Dev Behav Pediatr       Date:  2001-02       Impact factor: 2.225

4.  Serotonin transporter protein (SLC6A4) allele and haplotype frequencies and linkage disequilibria in African- and European-American and Japanese populations and in alcohol-dependent subjects.

Authors:  J Gelernter; H Kranzler; J F Cubells
Journal:  Hum Genet       Date:  1997-12       Impact factor: 4.132

5.  The substantia nigra and ventral tegmental area in Alzheimer's disease and Down's syndrome.

Authors:  W R Gibb; C Q Mountjoy; D M Mann; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

6.  Association of the serotonin transporter promoter regulatory region polymorphism and obsessive-compulsive disorder.

Authors:  D Bengel; B D Greenberg; G Corá-Locatelli; M Altemus; A Heils; Q Li; D L Murphy
Journal:  Mol Psychiatry       Date:  1999-09       Impact factor: 15.992

7.  Serotonin transporter promoter variants: Analysis in Indian autistic and control population.

Authors:  Subhrangshu Guhathakurta; Sagarmoy Ghosh; Swagata Sinha; Anindita Chatterjee; Shabina Ahmed; Susanta Roy Chowdhury; Prasanta Kumar Gangopadhyay; Saurabh Ghosh; Manoranjan Singh; Rajamma Usha
Journal:  Brain Res       Date:  2006-05-03       Impact factor: 3.252

8.  Antidepressant- and cocaine-sensitive human serotonin transporter: molecular cloning, expression, and chromosomal localization.

Authors:  S Ramamoorthy; A L Bauman; K R Moore; H Han; T Yang-Feng; A S Chang; V Ganapathy; R D Blakely
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

9.  Cerebrospinal fluid monoaminergic metabolites are elevated in adults with Down's syndrome.

Authors:  A D Kay; M B Schapiro; A K Riker; J V Haxby; S I Rapoport; N R Cutler
Journal:  Ann Neurol       Date:  1987-04       Impact factor: 10.422

10.  Diminished serotonin uptake in platelets of transgenic mice with increased Cu/Zn-superoxide dismutase activity.

Authors:  M Schickler; H Knobler; K B Avraham; O Elroy-Stein; Y Groner
Journal:  EMBO J       Date:  1989-05       Impact factor: 11.598

View more
  1 in total

1.  VNTR-DAT1 and COMTVal158Met Genotypes Modulate Mental Flexibility and Adaptive Behavior Skills in Down Syndrome.

Authors:  Laura Del Hoyo; Laura Xicota; Klaus Langohr; Gonzalo Sánchez-Benavides; Susana de Sola; Aida Cuenca-Royo; Joan Rodriguez; Jose Rodríguez-Morató; Magí Farré; Mara Dierssen; Rafael de la Torre
Journal:  Front Behav Neurosci       Date:  2016-10-17       Impact factor: 3.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.